Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × FluLaval × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 521 Specimen Handling 484 Magnetic Resonance Spectroscopy 416 Carboplatin 337 Cyclophosphamide 318 Biopsy 289 Cisplatin 282 Paclitaxel 254 Nivolumab 238 Gemcitabine 222 Radiotherapy 208 Bevacizumab 185 Dexamethasone 184 fludarabine 179 venetoclax 173 Oxaliplatin 151 Docetaxel 150 atezolizumab 145 Fluorouracil 145 durvalumab 142 Rituximab 138 Pemetrexed 137 Capecitabine 133 Doxorubicin 126 Radiation 125 Lenalidomide 122 Standard of Care 119 Prednisone 114 Radiosurgery 113 Drug Therapy 112

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡